B56.1 Rhodesiense trypanosomiasis

Name of the Condition

• Rhodesiense trypanosomiasis

Summary

Rhodesiense trypanosomiasis is a vector-borne parasitic disease caused by Trypanosoma brucei rhodesiense. It progresses through distinct stages, with early systemic symptoms and later central nervous system involvement. Endemic to sub-Saharan Africa, it is transmitted primarily by tsetse flies and represents the acute form of African trypanosomiasis.

Causes

The disease results from infection with Trypanosoma brucei rhodesiense parasites. Transmission occurs via the bite of infected tsetse flies, which introduce the parasites into the bloodstream. The parasites multiply and spread, eventually crossing the blood-brain barrier in later stages.

Risk Factors

• Residence in or travel to endemic regions of sub-Saharan Africa.
• Prolonged outdoor exposure in rural areas where tsetse flies are prevalent.
• Lack of protective measures against insect bites, such as insect repellent or clothing.
• Occupational activities involving contact with tsetse fly habitats, such as farming or hunting.
• Immunocompromised states may increase susceptibility to severe disease.

Symptoms

• Initial stage: Fever, headache, joint pain, and itching at the bite site (chancre).
• Swollen lymph nodes, particularly in the posterior cervical region (Winterbottom's sign).
• Progressive fatigue, weight loss, and intermittent fever.
• Later stage: Neurological symptoms, including confusion, personality changes, and sleep disturbances.

Diagnosis

Diagnosis involves clinical evaluation, microscopic examination of blood or lymph node aspirates for parasites, and serological tests. Lumbar puncture may be performed to assess central nervous system involvement in later stages. Molecular methods, such as PCR, can confirm infection in some cases.

Treatment Options

Treatment depends on disease stage and may include pentamidine for early-stage disease or melarsoprol for late-stage disease. Eflornithine or nifurtimox-eflornithine combination therapy may be used in specific cases. Supportive care, such as managing fever or neurological symptoms, is also important.

Prognosis and Follow-Up

Early diagnosis and treatment improve outcomes, but late-stage disease can be fatal if untreated. Follow-up includes monitoring for treatment response and potential relapse. Neurological recovery may be incomplete in advanced cases.

Complications

• Neurological damage, including cognitive impairment or seizures.
• Cardiac involvement, such as myocarditis.
• Multi-organ failure in severe cases.
• Death if left untreated.

Lifestyle & Prevention

• Avoiding tsetse fly bites in endemic areas through protective clothing and insect repellent.
• Using bed nets in affected regions.
• Seeking prompt medical care for symptoms after travel to endemic areas.
• Public health measures, such as vector control programs.

When to Seek Professional Help

Seek medical attention if experiencing fever, headache, or other symptoms after travel to sub-Saharan Africa, especially if exposure to tsetse flies is suspected. Early evaluation is critical for effective treatment.

Tips for Medical Coders

Use code B56.1 for Rhodesiense trypanosomiasis. Document the clinical stage (early or late) and any neurological involvement, as these details may impact coding and care planning. Ensure accurate reporting of exposure history and diagnostic findings to support the code assignment.